SCHEMBL7484874

SCHEMBL7484874

CC(=O)NCCNc1nnc(NC(=O)/C=C/c2ccccc2)s1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FSCN1 Q16658 1/20 0.49
GLS O94925 1/20 0.49
KMT2A Q03164 5/20 0.48
RAB9A P51151 4/20 0.48
KDM4E B2RXH2 3/20 0.48
NPC1 O15118 3/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
TP53 P04637 1/20 0.48
NFKB1 P19838 1/20 0.48
NFKB2 Q00653 1/20 0.48
RELA Q04206 1/20 0.48
ALDH1A1 P00352 5/20 0.47
HPGD P15428 4/20 0.47
NPSR1 Q6W5P4 3/20 0.47
LMNA P02545 1/20 0.47
MEN1 O00255 2/20 0.47
RXFP1 Q9HBX9 1/20 0.46
PARP1 P09874 1/20 0.46
EGFR P00533 2/20 0.45
MMP1 P03956 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7484883 1.00 FSCN1 (0.49) FSCN1GLSKMT2ARAB9AKDM4E
SCHEMBL7480810 0.87 MMP1 (0.55) FSCN1GLSKMT2ARAB9AKDM4E
SCHEMBL7480813 0.87 MMP1 (0.55) FSCN1GLSKMT2ARAB9AKDM4E
SCHEMBL7488537 0.84 FSCN1 (0.52) FSCN1GLSKMT2ARAB9AKDM4E
SCHEMBL7488527 0.84 FSCN1 (0.52) FSCN1GLSKMT2ARAB9AKDM4E
SCHEMBL7481144 0.83 MMP1 (0.58) FSCN1GLSKMT2ARAB9AKDM4E
SCHEMBL7481131 0.83 MMP1 (0.58) FSCN1GLSKMT2ARAB9AKDM4E
SCHEMBL7487114 0.83 EGFR (0.60) FSCN1GLSKMT2ARAB9AKDM4E
SCHEMBL7487107 0.83 EGFR (0.60) FSCN1GLSKMT2ARAB9AKDM4E
SCHEMBL7482017 0.82 ALDH1A1 (0.48) FSCN1GLSKMT2ARAB9AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1064273-B1 1,3,4-THIADIAZOLES USEFUL FOR THE TREATMENT OF CMV INFECTIONS UPJOHN CO (US) 2002-12-18 EP claimed
US-6150385-A VIRICIDE WITH ACTIVITY AGAINST CYTOMEGALO VIRUS (CMV), HERPES VIRUS INCLUDING VARICELLA ZOSTER VIRUS, THE EPSTEIN-BARR VIRUS, THE HERPES SIMPLEX VIRUS, AND THE HUMAN HERPES VIRUS TYPE 8 (HHV-8) PHARMACIA & UPJOHN COMPANY (US) 2000-11-21 US claimed
EP-1064273-B1 1,3,4-THIADIAZOLES USEFUL FOR THE TREATMENT OF CMV INFECTIONS UPJOHN CO (US) 2002-12-18 EP disclosed